Presentation is loading. Please wait.

Presentation is loading. Please wait.

Special Issues in Measurement

Similar presentations


Presentation on theme: "Special Issues in Measurement"— Presentation transcript:

1 Special Issues in Measurement
By Design Approach

2 Experimental Study The Intervention (exposure) What is it
What is the active ingredient What is the biological mechanism with which the active ingredient produces the desired outcome What are the inactive ingredients and are they inactive Is it standard for all or tailor-made Is it specified in enough detail to be reproducible Our Intervention

3 Intervention Description if the Same Study was Observational
Our Cohort Study Our Case-Control Study

4 Experimental Study Our Study Compliance
What are the likely problems with compliance Who (or what group) is more likely to have these problems How will compliance be assured, maximized and measured Cross-overs and/or selective drop-outs Our Study

5 Exposure “Adherence” if the Same Study was Observational
Our Cohort Study Our Case-Control Study

6 Experimental Study Co-intervention
What are the likely co-interventions Who are the most likely to seek out co-interventions How will the co-intervention affect your results How will you measure co-interventions Our Study

7 Co-Intervention Assessment if the Same Study was Observational
Our Cohort Study Our Case-Control Study

8 Experimental Study Blinding How will you measure blinding Intervention
Outcome Analysis Our Study

9 Experimental Study Outcome What is it
Biological link to Intervention ingredient When measured (science: in relation to outcome) How will you measure outcome Our Study

10 Effect of Physician Management Ability on Asthma Control
1996 Cohort 1996 1997 1998 X 05/20/97 Patient A’s Visit to the Study MD 1-year Baseline Assessment Period 05/20/96 11/20/96 1-year Outcome Assessment Period 05/20/985 03/1/975 03/15/98 Patient B’s Visit to the Study MD Baseline Assessment Period Outcome Assessment Period 09/15/98 1999 09/15/97 09/15/99 Example a. Example b. : Respiratory-related Visits to Study MDs : Other Visits to Study MDs : 6-Month Out of Control Evaluation : 1-year Asthma Status Evaluation x : First Day of Billing

11 Outcome Assessment if the Same Study was Observational
Our Cohort Study Our Case-Control Study


Download ppt "Special Issues in Measurement"

Similar presentations


Ads by Google